The European Medicines Agency’s (EMA’) human medicines committee (CHMP) has recommended two new medicines and three ...

The Food and Drug Administration (FDA) has expanded the approval of Pluvicto® (lutetium Lu 177 vipivotide tetraxetan) to include patients with ...

A European regulatory committee has rejected Eli Lilly's U.S.-approved Alzheimer's disease treatment over potentially ...

Eli Lilly, which is seeking European approval of Kisunla for the treatment of early symptomatic Alzheimer's, said it will seek re-examination by CHMP. The Indianapolis drugmaker said it remains ...

Lilly in a statement Friday said it will ask the CHMP to reexamine its opinion. Given the drug's approval by regulators in other countries, "Lilly remains confident in the safety and effectiveness of ...

Recommendation based on the findings from the Phase 3 studies (GALAXI programme and GRAVITI) in Crohn's disease 1,2< ...

Bristol Myers Squibb Receives Positive CHMP Opinion for the Subcutaneous Formulation of Opdivo® (nivolumab) Across Multiple Solid Tumor Indications ...

The European Union's drugs regulator on Friday rejected Eli Lilly's Alzheimer's drug, saying the treatment's small impact on ...

Today marks World TB Day 2025 with the WHO calling for more investment into TB treatment and research globally.

Krystal Biotech's VYJUVEK, a first-mover gene therapy for DEB, has received a positive CHMP recommendation. Read why KRYS ...

memorializing our ongoing revenue enhancement efforts and authorizing the petition to the Public Utilities Commission for approval of necessary tariff rate adjustments. This is not a general ...